El Impacto de La Validacion de Sistemas Criticos en La Calidad de Los Medicamentos Homeopaticos

8/17/2019 El Impacto de La Validacion de Sistemas Criticos en La Calidad de Los Medicamentos Homeopaticos

1/35

! !"#$%&' )* +$ ,$+!)$%!-. )*/!/&*"$/ %01&!%'/ #$%&$ ' $()*

$+,(*-.$/0 *. +$ %$+!)$) )* +'/"*)!%$"*.&'/ 2'"*'#3&!%'/ !

!"#$ &'()(*+ ,-.)/+") &+"01/'0


2/35

!4 ,5678597:;

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI F

! *J78>;975 8@9KL>;M56 ;>?585 5 M?5JNA 8> 65?>9@E76597:; O >J56K597:; 8> 6@A 85M@A @PM>;78@A >;65 9567Q9597:; O 8> 65A E?K>P5A >AE>9RQ95AS P5A585A

>; 9@;@97L7>;M@ 8>6 E?@9>A@S A7AM>L5 @ LNM@8@SE5?5 8>L@AM?5? TK;97@;567858S 9@;A7AM>;975 O?@PKAM>B42

345 6789::;9 ?@A'")- B(1.C.)- *' D)E(F.).FG" *' 5'*F.)H'"I+-2$


3/35

!4 ,5678597:; U9@;M44V

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI I

LIBERACIÓN

ORGANIZACIÓN

AREAS

EQUIPOS

INSUMOS

SISTEMAS PERSONAL

PROTOCOLO

EJECUCIÓN

APROBACIÓN RECHAZO

RESULTADOS

REPORTE

METODOS ANALITICOS

SISTEMAS CRITICOS

EQUIPOS Y PROCESOS

INSTALACIONES

PERSONAL

LIMPIEZA

SOFTWARE

REQUISI

TOS

VALI

DACIÓN


4/35

!!4 /7AM>L5A %?RW9@A

• )> 59K>?8@ 5 65A XK>;5A #?C9W95A 8>Y5P?79597:; ZX#Y[A\ U="#[A >; !;


5/35

!!4 /7AM>L5A %?RW9@A U9@;M44V

• &7E@A]

H4 $ $9@;8797@;58@ U2,$%VI4 $7?> %@LE?7L78@ +7P?> 8> $9>7M>

^4 ,5E@? +7LE7@

`4 =5A>A *AE>9756>A U.FS 'FS a _$#Vb4 'M?@A

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI `


6/35

H4 $B D />EFGHI b

H4H #?@P6>L5 8> 65 #K?>B5

a %@;M5L7;597:; .5MK?56 O#K?7Q9597:;4

a %@;M5L7;597:; X59M>?75;5

H4F !8>;WQ9597:; 8> !LEK?>B5A

a %K567M5WJ5 =>;>?56a$AE>9M@ a'6@?

a%@6@? a /5P@?

a

%K5;WM5WJ5 =>;>?56aE2 a&'%

a%@8K9WJ7858 a "79?@P7@6:


7/35

H4 $?J797@A #cP679@A 8> $;M@ >; /7W@ – $ $67L>;M597:;

– !;M>?95LP7@ !:;79@ U)!V

– 'AL@A7A !;J>?A5 U0'V

– )>AW6597:; UdY!V

– .5;@Q6M?597:; U.YV

– _6M?5Q6M?597:; U_YV

–

"79?@Q6M?597:; U"YV

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI e


8/35

H4 $B D />EFGHI f

.123 45 673489:3 673489:3 .123 45 $;8<#)5=> +?@>0

#?@8K9M@A ">8797;56>A*AMN?76>A

a#5?>;M>?56>Aa/@6K97@;>A 8> 2>L@87C67A7Aa/@6K97@;>A 8> )7C67A7A #>?7M@;>56a/@6K97@;>A E5?5 !??7Aa#?>E5?58@A .5A56>A O -W9@Aa#?>E5?58@A KA@ ?>9M56DJ5@A $ ED 97>?M@AKA@A J>M>?7;5?7@A

=?5;K6597:; #K?7Q9585 D #@M5P6> >; KA@ J>M4

0>9KP?7L7>;M@ #K?7Q9585

+7@Q67B58@ #K?7Q9585 h #?@84 *AMN?76 D #@M5P6> h #?@84 .@ *AMN?76

Y K > ; M > ] * K ? @ E > 5 ; " > 8

7 9 7 ; > A * J 5 6 K 5 W @ ; $ < > ; 9 O

U * " * $ V


9/35

H4 $B D />EFGHI i

.123 45 673489:3

AE5?597:;S A7 65 L7AL5 >A 8>9567858 AKE>?7@?4

#?@8K9M@AY5?L59NKW9@A*AMN?76>A#5?>;M>?56>A

a+5J58@ $A .@#5?>;M>?56>A

a+5J58@ $6 5; 65E?>E5?597:;S A7 65 L7AL5 >A 8>9567858 AKE>?7@?4

Y K > ; M > ] * K ? @ E > 5 ; " > 8

7 9 7 ; > A * J 5 6 K 5 W @ ; $ < > ; 9 O

U * " * $ V


10/35

H4 $A54

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI HG


11/35

H4 $9K>;975AH4b4H )>L@AM?5? kK> >6 58> A>?E?@8K9785 93@H1H:5@:5B5@:5 8>;M?@ 8> >AE>97Q9597@;>A

E5?5 AK KA@ >; 6@A E?@9>A@A 8> T5P?79597:;4

H4b4F *AM5P6>9>? >6 ;7J>6 8> 9@;M?@6 L79?@P7@6:9>A5?7@S kK> ?>kK>?7?C 8>6 >;M>;87L7>;M@ UE6>;@9@;@97L7>;M@V 8> 5LP5A 9@A5A] >6 8H3 45L 273489:3 I 45L

27395H3 45 OB D />EFGHI HH


12/35

H4 $A

&?5M5L7>;M@ 8> 5


13/35

H4 $ A7AM>L5A 8> 5 6@A A7AM>L5A 8> 5P> ?>567B5?A> 9@;T@?L> 5 65 Y*_" O AKA AKE6>L>;M@A4\345 6789::;=9 ?@A'")- B(1.C.)- *' D)E(F.).FG" *' 5'*F.)H'"I+-2

H4e4F +5 J5678597:; E5?5 6@A A7AM>L5A 8> 5 65AA7;M>A >M5E5A]

a %567Q9597:; U%)S %!S %'V

a %@L7A7@;5L7>;M@ U%@LL7AA7@;7;A>LE>m@

!:B, BO)(H).'AC.)/ ,"#F"''(F"# &AF*'$ P+/ Q$ R)I'( )"* :I')H :L-I'H-$

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI HI


14/35

H4 $ 8> )>A>LE>m@ @ 8> ,5678597:; 9@;AM58> M?>A T5A>A 8> L@;7M@?>@4 +@A W>LE@A E5?5

65A T5A>A A@;]• Y5A> H] F n ^ A>L5;5A

• Y5A> F] ^ A>L5;5A

• Y5A> I] H 5m@

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI H^


15/35

• )> 59K>?8@ 5 65 Y*_"S K; /7AM>L5 8> $P>?C9KLE67? 9@; 65A A7;M>A >AE>97Q9597@;>A 8> 9567858]

• N


16/35

• %@;96KA7:; 8> 65 ,5678597:;]

• #K>AM5 >; />?J797@ 8>6 /7AM>L5• #?@8K97? 5;M>L>;M> 9D >AE>97Q9597@;>A 8> 9567858 ?>kK>?785A•

*AM5P6>9>? 6@A #?@9>87L7>;M@A 8> 'E>?597:; 8>6 L7AL@• )>Q;7? O L@;7M@?>5? 6@A 6RL7M>A 8> 9@;M?@6 U56>?M5 O 5997:;V• *AM5P6>9>? 65A ?KW;5A 8> "5;M>;7L7>;M@ #?>J>;WJ@

• *67L7;5? TK>;M>A E?@P5P6>A 8> 9@;M5L7;597:; r5975 6@A E?@8K9M@A• /@E@?M> ?> 65 9567858 8> 6@A E?@8K9M@A T5P?7958@A•

%@;@97L7>;M@ 8> 6@A E?@8K9M@A O 6@A E?@9>A@A4• %@AM@A @E>?5WJ@A 9@;M?@658@A O ?>8K978@A D 7;87>;M> E?7;97E56 >; 6@A

E?@9>A@A 8> T5P?79597:; O 67LE7>B5 4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Hb

H4 $


17/35

• )5O575@91 6@A *AM58@A _;78@A ">o795;@A J7;M> UY*_"V4• _;7M>8 /M5M>A #r5?L59@E>75 U_/#V• *K?@E>5; #r5?L59@Er>75 %@LL7AA7@;4

•

*K?@E>5; ">8797;>A *J56K5W@; $;9O U*"*$V• d2' =@@8 "5;KT59MK?7;< #?59W9>A] d5M>? T@? #r5?L59>KW956 _A>

UIi 0>E@?MV• &AS) K)() /) T)/F*)* *'/ ;#A) B+I)E/'U >V$ ,*$ &F"'E() W 45:$


18/35

a 2,$% a

Z/7AM>L5 8> $7?> $9@;8797@;58@ O %56>T5997:;\

E@? AKA A7; 7;5W;;W65W@; 5;8 $7? %@;87W@;7;B D />EFGHI Hf

F4 $7?> $LP7>;M56 a 2,$%


19/35

• -R+ STU VV$W!XSWYZ

• [>X>X>\ +5A C?>5AS >kK7E@A 8> T5P?79597:; OE?@9>A@A 8>P>; 9@;M5? 9@; 6@A A7AM>L5A 9?RW9@A

?>kK>?78@A M56>A 9@L@] 2,$%S 57?> 9@LE?7L78@S5;M?>@M?@A4

• [>X>X>[ *6 A7AM>L5 2,$% 8>P> >AM5? 87A>m58@ 8>

T@?L5 M56 kK> E>?L7M5 9KLE67? 9@; 65 965A7Q9597:;8>6 C?>5 ?>kK>?785 8> 59K>?8@ 56 $EN;879>;@?L5WJ@ $4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Hi

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


20/35

• [>X>X>WW /> 8>P> >J7M5? kK> 65 7;AM56597:; O >6599>A@ E5?5 L5;M>;7L7>;M@ 56 2,$%S 5L5A 8> A@E@?M> A>5 K;5 TK>;M> 8>9@;M5L7;597:; E5?5 >6 E?@8K9M@4

• [>X>X>WX .@ 8>P> >o7AW? ?>97?9K6597:; 8> 57?>>; 6@A A7AM>L5A 2,$% 8> C?>5A 8@;8> A>

E?@9>A5; @?A O>J7M5? AK 67P>?597:; 56 L>87@ 5LP7>;M>4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI FG

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


21/35

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI FH

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


22/35

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI FF

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V

• Y>\W +5419B965 8> AKPAM5;975A 8> @?7; ;5MK?56 @A7;MNW9@ kK> M>; A> E?>A>;M>>; T@?L5 T5?L59NKW95 O A> 78>;WQkK> 9@L@M56 E@? AK 59WJ7858 T5?L59@6:


23/35

• Y>X] NB D />EFGHI FI

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


24/35

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI F^

21. Apéndice normativo A. Areas de fabricación

Y5P?79597:; O L@;M5j> 8> 8K9M@A

+3@: $LP7>;M56 a 2,$% U9@;M44V


25/35

• _;7858>A "5;>j58@?5A 8> $7?> U_"$V

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI F`

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


26/35

• 0>8 8> )K9M@A O 8>LCA 9@LE@;>;M>A4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Fb

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


27/35

• /7AM>L5] HGG t !;O>997:; D *oM?5997:;

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Fe

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


28/35

• /7AM>L5] 0>97?9K6597:;4 fGt!;O>997:;DFGt*oM?5997:;

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Ff

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


29/35

• U>[ ,5678597:; 8>6 A7AM>L5 2,$%4

• U>[>W *6 A7AM>L5 2,$% 8>P> J56785?A> M@L5;8@ >;9@;A78>?597:; 65 9567Q9597:; 8> 56 L>;@A 6@A

A7;M>A E5?CL>M?@A] I'HK'()IA() L OAH'*)**' /)- 1(')- JA' )/FH'"I)U N+/AH'" *' F"L'..FG" L'aI()..FG" *' )F('U *F['('".F)/'- *' K('-FG" '"I('/)- 1(')-U "bH'(+ *' .)HEF+- *' )F('U .+"I'+ *'

K)(c.A/)-S uKj@A 8> 57?>S ;7J>6>A 8> 67LE7>B5SJ>6@97858 8> uKj@ O E?K>P5A 8> 7;M> $LP7>;M56 a 2,$% U9@;M44V


30/35

• ,5678597:;]

–

%567Q9597:; 8> )7A>m@ – %567Q9597:; 8> !;AM56597:;

– %567Q9597:; 8> 'E>?597:; UO %@LL7AA7@;7; )>A>LE>m@

•

%65A7Q9597:; 8> 3?>5 U$EN;879> $ n .'" G`iV

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI IG

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


31/35

• ,5678597:;

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI IH

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


32/35

• X>;>Q97@A 8> 65 ,5678597:;]a 'EWL7B5? TK;97@;5L7>;M@ 8>6 A7AM>L5

a ">j@? 9@;@97L7>;M@ 8> ;K>AM?@A E?@9>A@A

a

#5?CL>M?@A %?RW9@A a X5j@ %@;M?@6

a 0>8K997:; 8> T59M@?>A 9@;M5L7;5;M>A 56 E?@8K9M@a *oM>?;@A a !;M>?;@A U9@;M5L7;597:; 9?KB585V

a *Q97>;M5? 65 E?@8K9WJ7858 65P@?56

a

$E@?M> 8> 9567858 5 6@A E?@8K9M@A

a %KLE67L7>;M@ 0>B D />EFGHI IF

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


33/35

• 0>T>?>;975A X7P67@


34/35

• $ $LP7>;M56 U2,$%V]

?;HE+- -F-I'H)- ('JAF'('" '-I)( N)/F*)*+-2

–

$L:3 1B2L5A 9?RW9@A kK> EK>8>;5T>9M5? 65 95E597858 8> K;5 7;AM56597:;T5?L59NKW95 E5?5 9KLE67? 9@; AK @Pj>WJ@ 8>E?@E@?97@;5? E?@8K9M@ A>Q95B E5?5 >6

E597>;M>4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI I^

I4 %@;96KA7:;


35/35

&().F)-

!;?5?8@ *A956@;5 =@;BC6>BA@E@?M>xJ5678597@;y>A9567;L>o79@49@L4Lo

zzz4>A9567;L>o79@49@L4Lo

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI I`

^4 %@L>;M5?7@A

El Impacto de La Validacion de Sistemas Criticos en La Calidad de Los Medicamentos Homeopaticos

Documents

Transcript of El Impacto de La Validacion de Sistemas Criticos en La Calidad de Los Medicamentos Homeopaticos